TickerFacts.

A business in context

PACB research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-06 · 0001384133-26-000004

  2. 4 · Ownership change

    Report date 2026-08-17 · 0001299130-26-000128

  3. 4 · Ownership change

    Report date 2026-08-10 · 0001299130-26-000126

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001299130-26-000122

  5. 8-K · Current report

    Report date 2026-07-30 · 0001299130-26-000117 · Items 2.02,2.05,5.02,7.01,9.01

  6. 8-K · Current report

    Report date 2026-07-08 · 0001299130-26-000111 · Items 5.02

  7. 4 · Ownership change

    Report date 2026-06-03 · 0001299130-26-000108

  8. 4 · Ownership change

    Report date 2026-06-03 · 0001299130-26-000106

  9. 4 · Ownership change

    Report date 2026-06-03 · 0001299130-26-000104

  10. 4 · Ownership change

    Report date 2026-06-03 · 0001299130-26-000102

  11. 4 · Ownership change

    Report date 2026-06-03 · 0001299130-26-000100

  12. 8-K · Current report

    Report date 2026-06-03 · 0001299130-26-000092 · Items 5.02,5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001299130-26-000081

  14. 8-K · Current report

    Report date 2026-05-07 · 0001299130-26-000076 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-03 · 0001299130-26-000064

  16. 8-K · Current report

    Report date 2026-03-02 · 0001299130-26-000053 · Items 5.02,7.01

  17. 8-K · Current report

    Report date 2026-03-03 · 0001299130-26-000046 · Items 5.02,7.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001299130-26-000034

  19. 8-K · Current report

    Report date 2026-02-12 · 0001299130-26-000017 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-01-28 · 0001299130-26-000012 · Items 5.02

  21. 8-K · Current report

    Report date 2026-01-30 · 0001104659-26-009014 · Items 1.01,2.01,7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001299130-26-000005 · Items 2.02,8.01,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001299130-25-000168

  24. 8-K · Current report

    Report date 2025-11-05 · 0001299130-25-000165 · Items 2.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001299130-25-000156

  26. 8-K · Current report

    Report date 2025-08-07 · 0001299130-25-000152 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-06-04 · 0001299130-25-000140 · Items 5.02,5.07,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001299130-25-000102

  29. 8-K · Current report

    Report date 2025-05-08 · 0001299130-25-000099 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-06-04 · 0001299130-25-000090

  31. 8-K · Current report

    Report date 2025-04-09 · 0001299130-25-000083 · Items 2.02,2.05,9.01

  32. 8-K · Current report

    Report date 2025-03-24 · 0001299130-25-000072 · Items 5.02,7.01,9.01

  33. 10-K · Annual report

    Report date 2024-12-31 · 0001299130-25-000061

  34. 8-K · Current report

    Report date 2025-03-07 · 0001299130-25-000053 · Items 1.01,2.03

  35. 8-K · Current report

    Report date 2025-02-13 · 0001299130-25-000033 · Items 2.02,9.01

  36. 8-K/A · Current report

    Report date 2025-01-24 · 0001299130-25-000027 · Items 5.02

  37. 8-K · Current report

    Report date 2025-01-24 · 0001299130-25-000015 · Items 5.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-01-14 · 0001299130-25-000011 · Items 2.02,8.01,9.01

  39. 8-K · Current report

    Report date 2024-12-11 · 0001299130-24-000200 · Items 5.02

  40. 8-K/A · Current report

    Report date 2024-11-11 · 0001299130-24-000198 · Items 5.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

3 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-17
2026-08-18
Van Oene MarkS · Sale
Disposed
Common Stock26911.01.13
2026-08-10
2026-08-11
Van Oene MarkA · Grant / award
Acquired
Common Stock489130.00.0
2026-08-10
2026-08-11
Van Oene MarkA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
1967888.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001299130PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
529900F1BWRE1M0KZN89
GLEIF legal name
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2022-10-18T23:30:04Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Pacific Biosciences · alias · wikidata
  • PACB · alias · wikidata
  • PacBio · alias · wikidata
  • PACIFIC BIOSCIENCES OF CALIFORNIA INC · former SEC name · 2005-08-25 to 2013-02-05
  • NANOFLUIDICS INC · former SEC name · 2004-07-28 to 2004-07-28
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$154.01M$165.43M
2023-12-31$200.52M$221.72M
2022-12-31$128.30M$147.70M
2021-12-31$130.51M$162.26M
2020-12-31$78.89M$102.71M
2019-12-31$90.89M$119.78M
2018-12-31$78.63M$105.50M
2017-12-31$93.47M$128.48M

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗